Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1980 1
1985 2
1986 1
1987 2
1988 1
1989 3
1990 1
1992 2
1993 1
1994 2
1997 5
1998 2
1999 4
2000 1
2002 2
2004 3
2005 4
2006 5
2007 3
2008 1
2009 3
2010 3
2011 8
2012 5
2013 7
2014 9
2015 7
2016 7
2017 5
2018 9
2019 6
2020 2
2021 2
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 25530452

116 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics of oral rufinamide in dogs.
Wright HM, Chen AV, Martinez SE, Davies NM. Wright HM, et al. J Vet Pharmacol Ther. 2012 Dec;35(6):529-33. doi: 10.1111/j.1365-2885.2011.01353.x. Epub 2011 Dec 2. J Vet Pharmacol Ther. 2012. PMID: 22132708 Clinical Trial.
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA. Bergman AJ, et al. Clin Ther. 2006 Jan;28(1):55-72. doi: 10.1016/j.clinthera.2006.01.015. Clin Ther. 2006. PMID: 16490580 Clinical Trial.
Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study.
Arzimanoglou A, Ferreira JA, Satlin A, Mendes S, Williams B, Critchley D, Schuck E, Hussein Z, Kumar D, Dhadda S, Bibbiani F. Arzimanoglou A, et al. Eur J Paediatr Neurol. 2016 May;20(3):393-402. doi: 10.1016/j.ejpn.2015.12.015. Epub 2016 Jan 11. Eur J Paediatr Neurol. 2016. PMID: 26805435 Free article. Clinical Trial.
116 results